BackHemogenyx Pharmaceuticals Plc Overview

Hemogenyx Pharmaceuticals Plc Receivables

Track Hemogenyx Pharmaceuticals Plc's receivables ($310K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$313585.00
↓ 8.65% YoYΔ $-29708.00 vs prior year quarter

Peer trimmed avg / median

Loading

Hemogenyx Pharmaceuticals Plc Receivables History

Loading

Hemogenyx Pharmaceuticals Plc vs. peers: Receivables Comparison

Loading

Hemogenyx Pharmaceuticals Plc Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Hemogenyx Pharmaceuticals Plc (HOPHF) FAQ

Hemogenyx Pharmaceuticals Plc (HOPHF) currently reports a receivables of $310K as of June 2026. That compares with $340K in the prior-year period — down 8.7% year over year. Use the charts on this page to explore Hemogenyx Pharmaceuticals Plc's receivables history and peer comparisons.

Hemogenyx Pharmaceuticals Plc's receivables decreased from $340K to $310K — a 8.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hemogenyx Pharmaceuticals Plc reported $310K in receivables as of June 2026. That compares with $340K in the prior-year period — down 8.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $310K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hemogenyx Pharmaceuticals Plc, and consider following HOPHF for alerts when major investors trade the stock.

Hemogenyx Pharmaceuticals Plc is classified in the Healthcare sector. On receivables, it currently shows $310K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HOPHF with unrelated industries.